Medication info
Newspirin Enteric-Coated Tablet 100 mg (Aspirin)

Newspirin Enteric-Coated Tablet 100 mg (Aspirin)

OTC medicationTablet경구
Ingredient · strength
Aspirin›100mg / 1 tablet
Manufacturer / importer
(주)다산제약
Appearance
White, round enteric-coated film-coated tablets
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 201801356 · Notified 2018.03.28 · Insurance code 678600810

Summary

Main use
Inhibition of thrombus formation and reduction of cardiovascular risk
Who takes it
Adults
Adult dose
For adults, take one tablet once daily before meals with plenty of water.

Ingredients

Manufacturer
(주)다산제약

Efficacy & effects

Inhibition of thrombus formation and reduction of cardiovascular risk

  • Myocardial infarction
  • cerebral infarction
  • unstable angina
View approved original text

This medication helps prevent and mitigate symptoms by inhibiting thrombus formation in major cardiovascular diseases such as myocardial infarction, cerebral infarction, and unstable angina. Additionally, it helps prevent thrombus formation after coronary artery bypass surgery or percutaneous coronary intervention, supporting the therapeutic effect. It is also used to reduce cardiovascular risk in high-risk patients with multiple risk factors such as a family history of ischemic heart disease, hypertension, hypercholesterolemia, obesity, and diabetes. Its efficacy makes it effective for the prevention and treatment of cardiovascular diseases.

How to take

Adult dose

For adults, take one tablet once daily before meals with plenty of water.

Precautions

This medication should be discussed with a doctor or pharmacist if taken by individuals who regularly consume more than three glasses of alcohol daily. This medication may cause gastrointestinal bleeding, so it is safer for individuals with gastrointestinal diseases to avoid taking it. Individuals with a history of allergic reactions to this medication, patients with peptic ulcers, those with a history of aspirin-induced asthma, hemophilia patients, individuals with severe liver or kidney dysfunction, patients with severe heart failure, those with a tendency to bleed, individuals taking high doses of methotrexate, and pregnant women in their third trimester should not take this medication. Patients with kidney or cardiovascular issues, those with a history of liver disease, individuals with blood disorders, bronchial asthma, patients undergoing surgery, children under three years of age, those with hypersensitivity to analgesics or anti-inflammatory drugs, the elderly, those taking anticoagulants, and individuals with glucose-6-phosphate dehydrogenase deficiency should use this medication cautiously. This medication may cause hypersensitivity reactions, skin rashes, and in severe cases, serious skin diseases like Stevens-Johnson syndrome, so if abnormal symptoms occur, discontinue use immediately and consult a physician. Blood-related adverse reactions may include anemia or thrombocytopenia, requiring careful observation. Gastrointestinal side effects may present as loss of appetite, heartburn, stomach pain, nausea, vomiting, and prolonged use may increase the risk of gastrointestinal bleeding or ulcers. This medication may cause neurological symptoms such as dizziness, headaches, and tinnitus; therefore, dosage adjustments or discontinuation should be considered if symptoms worsen. Liver dysfunction or kidney dysfunction has been rarely reported, so if any abnormal symptoms arise, immediate consultation with a physician is necessary. This medication should be carefully administered at minimal doses to children and the elderly, and caution is needed if infections are present as it may worsen them. If this medication was taken within one week prior to surgery, there is an increased risk of bleeding, so it should be reported to the operating physician. Overdose may result in signs of poisoning, which can pose a life-threatening risk, so strict adherence to dosage is essential. This medication can interact with several drugs, so if other medications are being taken, consultation with a physician or pharmacist is necessary. During the early and middle stages of pregnancy, it should be taken only at minimal doses if needed, and in late pregnancy, it should not be used due to potential risks to both the fetus and the mother. While breastfeeding, it is advisable not to take this medication as it can be transferred through breast milk. This medication should be kept out of reach of children and stored in its original container for safety.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, shock and anaphylactic symptoms, asthma attacks, systemic flushing, angioedema, severe allergic reactions, severe rash accompanied by high fever, blisters, skin peeling, oral/ocular mucosal pain, Reye's syndrome (toxic epidermal necrolysis), Stevens-Johnson syndrome, exfoliative dermatitis, respiratory issues, yellowing of the skin or eyes (jaundice), profound fatigue, liver abnormalities (jaundice)

Mild side effects

  • Erythema
  • itching
  • nasal congestion
  • occasional rash
  • rhinitis-like symptoms
  • conjunctivitis
  • loss of appetite
  • heartburn
  • stomach pain
  • nausea
Show 16 more
  • vomiting
  • tinnitus
  • hearing loss
  • dizziness
  • headaches
  • agitation
  • rash
  • lymphadenopathy
  • facial swelling
  • hepatitis
  • nephritis
  • hematological abnormalities
  • myocarditis
  • myositis
  • hyperventilation
  • metabolic acidosis

Not everyone experiences these, and they can vary from person to person.

Interactions

Drug interactions

This medication may increase the risk of bleeding or decrease renal function when combined with other non-steroidal anti-inflammatory drugs and salicylates. High doses of methotrexate (15 mg or more) should not be used together for a week. Drug interactions may occur with anticoagulants, ibuprofen, naproxen, some non-steroidal anti-inflammatory drugs, thrombolytics, other platelet inhibitors, hemostatic agents, and diabetes treatments (insulin, tolbutamide, etc.).

Storage

Store this medication in a tightly sealed container to prevent air or moisture ingress, and keep it in a cool place between 1 to 25 degrees Celsius. This storage method helps maintain the medication's efficacy and prevents deterioration.

Appearance and packaging

Appearance

White, round enteric-coated film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.